102 related articles for article (PubMed ID: 15112439)
1. [Fragment-based drug design using stereoisomers. A case study of analogues of the phenol group in the Bioster database].
Ujváry I; Györffy W; Lopata A
Acta Pharm Hung; 2003; 73(3):163-9. PubMed ID: 15112439
[TBL] [Abstract][Full Text] [Related]
2. Quantum Isostere Database: a web-based tool using quantum chemical topology to predict bioisosteric replacements for drug design.
Devereux M; Popelier PL; McLay IM
J Chem Inf Model; 2009 Jun; 49(6):1497-513. PubMed ID: 19453153
[TBL] [Abstract][Full Text] [Related]
3. Toward an ab initio fragment database for bioisosterism: dependence of QCT properties on level of theory, conformation, and chemical environment.
Devereux M; Popelier PL; McLay IM
J Comput Chem; 2009 Jun; 30(8):1300-18. PubMed ID: 19003976
[TBL] [Abstract][Full Text] [Related]
4. Use of reduced graphs to encode bioisosterism for similarity-based virtual screening.
Birchall K; Gillet VJ; Willett P; Ducrot P; Luttmann C
J Chem Inf Model; 2009 Jun; 49(6):1330-46. PubMed ID: 19485397
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists.
Wu WL; Burnett DA; Spring R; Greenlee WJ; Smith M; Favreau L; Fawzi A; Zhang H; Lachowicz JE
J Med Chem; 2005 Feb; 48(3):680-93. PubMed ID: 15689153
[TBL] [Abstract][Full Text] [Related]
6. RelACCS-FP: a structural minimalist approach to fingerprint design.
Hu Y; Lounkine E; Batista J; Bajorath J
Chem Biol Drug Des; 2008 Nov; 72(5):341-9. PubMed ID: 19012570
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors.
Lin EY; Guckian KM; Silvian L; Chin D; Boriack-Sjodin PA; van Vlijmen H; Friedman JE; Scott DM
Bioorg Med Chem Lett; 2008 Oct; 18(19):5245-8. PubMed ID: 18783948
[TBL] [Abstract][Full Text] [Related]
8. Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets.
Baurin N; Aboul-Ela F; Barril X; Davis B; Drysdale M; Dymock B; Finch H; Fromont C; Richardson C; Simmonite H; Hubbard RE
J Chem Inf Comput Sci; 2004; 44(6):2157-66. PubMed ID: 15554686
[TBL] [Abstract][Full Text] [Related]
9. Selection of molecules based on shape and electrostatic similarity: proof of concept of "electroforms".
Jennings A; Tennant M
J Chem Inf Model; 2007; 47(5):1829-38. PubMed ID: 17824684
[TBL] [Abstract][Full Text] [Related]
10. The quest for bioisosteric replacements.
Wagener M; Lommerse JP
J Chem Inf Model; 2006; 46(2):677-85. PubMed ID: 16562998
[TBL] [Abstract][Full Text] [Related]
11. Absorption spectrometric and thermodynamic study of charge transfer complexes of menadione (Vitamin K3) with a series of phenols.
Pal P; Bhattacharya S; Mukherjee AK; Mukherjee DC
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Mar; 61(5):879-85. PubMed ID: 15683792
[TBL] [Abstract][Full Text] [Related]
12. A CoMSIA study on the adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues.
Caballero J; Fernández M; González-Nilo FD
Bioorg Med Chem; 2008 May; 16(9):5103-8. PubMed ID: 18359230
[TBL] [Abstract][Full Text] [Related]
13. Chemical database mining through entropy-based molecular similarity assessment of randomly generated structural fragment populations.
Batista J; Bajorath J
J Chem Inf Model; 2007; 47(1):59-68. PubMed ID: 17238249
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
[TBL] [Abstract][Full Text] [Related]
15. Extraction and analysis of chemical modification patterns in drug development.
Shigemizu D; Araki M; Okuda S; Goto S; Kanehisa M
J Chem Inf Model; 2009 Apr; 49(4):1122-9. PubMed ID: 19391632
[TBL] [Abstract][Full Text] [Related]
16. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds.
Ertl P; Jelfs S; Mühlbacher J; Schuffenhauer A; Selzer P
J Med Chem; 2006 Jul; 49(15):4568-73. PubMed ID: 16854061
[TBL] [Abstract][Full Text] [Related]
17. In silico identification of bioisosteric functional groups.
Ertl P
Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
[TBL] [Abstract][Full Text] [Related]
18. Proline-rich proteins--deriving a basis for residue-based selectivity in polyphenolic binding.
Croft AK; Foley MK
Org Biomol Chem; 2008 May; 6(9):1594-600. PubMed ID: 18421391
[TBL] [Abstract][Full Text] [Related]
19. Use of benzofuran for concomitant protection of aldehyde and phenol groups in the preparation of mycophenolic acid analogues.
Fardis M; Mertzman M; Thomas W; Kirschberg T; Collins N; Polniaszek R; Watkins WJ
J Org Chem; 2006 Jun; 71(13):4835-9. PubMed ID: 16776510
[TBL] [Abstract][Full Text] [Related]
20. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
Guo ZR
Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
